Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsWith over a decade of experience in phage display technology, Creative Biolabs can provide a series of antibody or peptide libraries that are available for licensing or direct screening. These ready-to-use libraries are invaluable resources for isolating target-specific binders for various research, diagnostic or therapeutic applications. Highlights
Creative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
HighlightsSolute carrier family 2, facilitated glucose transporter member 9 (SLC2A9), also known as glucose transporter type 9 (GLUT-9), is a protein that in humans is encoded by the SLC2A9 gene. As a member of the SLC2A facilitative glucose transporter family which play a significant role in maintaining glucose homeostasis, SLC2A9 is associated with the development and survival of chondrocytes in cartilage matrices.
| Basic Information of SLC2A9 | |
| Protein Name | Solute carrier family 2, facilitated glucose transporter member 9 |
| Gene Name | SLC2A9 |
| Aliases | Glucose transporter type 9, GLUT-9 |
| Organism | Homo sapiens (Human) |
| UniProt ID | Q9NRM0 |
| Transmembrane Times | 12 |
| Length (aa) | 540 |
| Sequence | MARKQNRNSKELGLVPLTDDTSHAGPPGPGRALLECDHLRSGVPGGRRRKDWSCSLLVASLAGAFGSSFLYGYNLSVVNAPTPYIKAFYNESWERRHGRPIDPDTLTLLWSVTVSIFAIGGLVGTLIVKMIGKVLGRKHTLLANNGFAISAALLMACSLQAGAFEMLIVGRFIMGIDGGVALSVLPMYLSEISPKEIRGSLGQVTAIFICIGVFTGQLLGLPELLGKESTWPYLFGVIVVPAVVQLLSLPFLPDSPRYLLLEKHNEARAVKAFQTFLGKADVSQEVEEVLAESRVQRSIRLVSVLELLRAPYVRWQVVTVIVTMACYQLCGLNAIWFYTNSIFGKAGIPPAKIPYVTLSTGGIETLAAVFSGLVIEHLGRRPLLIGGFGLMGLFFGTLTITLTLQDHAPWVPYLSIVGILAIIASFCSGPGGIPFILTGEFFQQSQRPAAFIIAGTVNWLSNFAVGLLFPFIQKSLDTYCFLVFATICITGAIYLYFVLPETKNRTYAEISQAFSKRNKAYPPEEKIDSAVTDGKINGRP |
SLC2A9 or Glut9 is a voltage sensitive urate transporter which is almost expressed in the kidney and liver and at low levels in the small intestine, placenta, lung, and leucocytes. To date, two transcript variants encoding distinct isoforms have been identified namely GLUT9a and GLUT9b. GLUT9b is mainly expressed in the kidney, placenta, and liver, whereas GLUT9a shows a broader tissue distribution. In addition to playing a role in the development and survival of chondrocytes in cartilage matrices, SLC2A9 has also been identified as a key component for renal re-absorption of uric acid. It has been reported that the increased expression of SLC2A9 is associated with hyperuricemia and gout, whereas loss of function leads to severe hypouricemia. What’s more, studies have shown that genetic variants of the SLC2A9 transporter have been linked to increased risk of development of numerous diseases, such as hyperuricemia, gout and Alzheimer's disease.
Fig.1 A schematic diagram of the mechanism underlying the neuroprotective effects of urate on dopaminergic neurons. (Bi, 2018)
This article is the first report describing SLC22A12 and SLC2A9 mutations in Spanish patients.
This article aims to investigate whether GLUT9, ABCG2 and URAT1 gene single nucleotide polymorphisms (SNPs) are able to influence uric acid levels and allopurinol response in patients with hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency. It suggests that GLUT9 SNPs could influence the renal handling of uric acid and modulate serum urate levels and the response to treatment in patients with uric acid overproduction due to HPRT deficiency.
This research is conducted to study the roles and mechanisms of SLC2A9 in hepatocellular carcinoma (HCC). The results demonstrate that SLC2A9 may be a novel tumor suppressor gene and a potential therapeutic target in HCC.
This article indicates that urate transport in hSLC2A9 involves several structural elements rather than just a unique substrate binding pocket.
This article demonstrates that Glut9 expression is downregulated by male-pattern growth hormone secretion but is upregulated by activation of aryl hydrocarbon receptor and peroxisome proliferator-activated receptor α signaling in mice.
To provide high-quality products, we have developed an advanced Magic™ membrane protein production platform. Aided by our versatile Magic™ anti-membrane protein antibody discovery platform, we also provide customized anti-SLC2A9 antibody development services.
With extensive experience and professional scientists, Creative Biolabs is dedicated to promoting global customers’ programs. Except for SLC2A9 membrane protein products, we also provide other membrane protein preparation services to meet every client’s specific requirements. To learn more information, please feel free to contact us for more information.
Reference
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
